Moderna (NASDAQ:MRNA) Research Coverage Started at Citigroup
Citigroup assumed coverage on shares of Moderna (NASDAQ:MRNA – Free Report) in a research report report published on Thursday morning, MarketBeat.com reports. The brokerage issued a neutral rating and a $40.00 price target on the stock. MRNA has been the subject of a number of other research reports. Evercore ISI set a $50.00 price target […]
Citigroup assumed coverage on shares of Moderna (NASDAQ:MRNA – Free Report) in a research report report published on Thursday morning, MarketBeat.com reports. The brokerage issued a neutral rating and a $40.00 price target on the stock. MRNA has been the subject of a number of other research reports. Evercore ISI set a $50.00 price target […]
